Leadership Overview
West Pharmaceutical Services has 4 executives leading key functions including finance, human resources, medical affairs, and regional operations.
Driven by a commitment to innovation, West Pharmaceutical Services manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products, impacting global health outcomes.
Driven by a commitment to innovation, West Pharmaceutical Services manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products, impacting global health outcomes.
Leadership Roles at West Pharmaceutical Services
Robert McMahon - Senior Vice President & Chief Financial Officer
Robert McMahon, the Senior Vice President & Chief Financial Officer at West Pharmaceutical Services, directs all financial operations and strategic fiscal planning. Overseeing global accounting, treasury, and investor relations, McMahon ensures robust financial health and compliance across all regions. This leadership role involves managing capital allocation, driving profitability, and optimizing financial performance to support the company's growth objectives in manufacturing packaging components and delivery systems for injectable drugs. By analyzing market trends and financial data, Robert McMahon provides critical insights that inform executive decision-making and long-term business strategy. The Chief Financial Officer's purview extends to risk management and ensuring the financial integrity of West Pharmaceutical Services' international operations, particularly in the United States, Germany, France, and other European countries. McMahon's financial acumen directly supports the company's mission to deliver high-quality healthcare products.

Donald McMillan - President, Americas
Donald McMillan, the President, Americas at West Pharmaceutical Services, directs all operational and strategic initiatives across North and South America. Overseeing sales, market development, and customer relations within these key regions, McMillan drives business growth and ensures the effective delivery of packaging components and delivery systems for injectable drugs. This leadership position involves managing regional performance, optimizing supply chain logistics, and fostering strong client partnerships throughout the Americas. By executing tailored market strategies, Donald McMillan enhances West Pharmaceutical Services' presence and impact in the pharmaceutical and healthcare sectors. The President, Americas' responsibilities include achieving revenue targets, expanding market share, and ensuring operational excellence in alignment with the company's global objectives. McMillan's regional leadership is vital to the company's success in serving its diverse customer base.
Annette Favorite - Senior VP & Chief Human Resources Officer
Annette Favorite, the Senior VP & Chief Human Resources Officer at West Pharmaceutical Services, architects the company's global human capital strategy. Overseeing talent acquisition, development, and retention, Favorite cultivates a high-performance culture essential for innovation in healthcare product manufacturing. This executive position involves shaping employee engagement initiatives and ensuring alignment with West Pharmaceutical Services' mission to provide critical packaging and delivery systems for injectable drugs. By fostering a supportive and dynamic work environment, Annette Favorite drives organizational effectiveness across the United States, Germany, France, and other international markets. The Chief Human Resources Officer's responsibilities include managing compensation and benefits, promoting diversity and inclusion, and ensuring compliance with labor laws worldwide. Favorite's strategic leadership in human resources directly contributes to the company's ability to meet global demand for its specialized products.

Anya Harry - Vice President & Chief Medical Officer
Anya Harry, the Vice President & Chief Medical Officer at West Pharmaceutical Services, spearheads the company's medical affairs and clinical strategy. Overseeing the scientific and clinical aspects of packaging components and delivery systems for injectable drugs, Harry ensures product safety and efficacy. This critical role involves providing medical expertise to guide product development and regulatory submissions, directly supporting West Pharmaceutical Services' commitment to advancing healthcare solutions. By collaborating with research and development teams, Anya Harry drives innovation in drug delivery technologies across global markets. The Chief Medical Officer's focus includes staying abreast of medical advancements and regulatory requirements in the United States, Germany, France, and beyond. Harry's medical insights are fundamental to maintaining the company's reputation for quality and reliability in the pharmaceutical packaging sector.
Explore Leadership Teams in Manufacturing
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Company Leadership


DS
CAIRE, headquartered in Ball Ground, Georgia, is a manufacturer of oxygen supply equipment. They specialize in stationary and portable oxygen concentrators.
Company Leadership FH
RA
MM
YS
BTL Industries has become one of the worlds major manufacturers of medical and aesthetic equipment with direct offices in more than 80 countries around the world.
Company Leadership QC
JL